Pylarify (piflufolastat f 18).
Ended Awarded Last action
- Contract number
- 36C26025F0276
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $721,744
Award facts
- Contract value 100% obligated
- $721,744.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The $721,744 firm fixed-price delivery order is for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer.
The contract is not set aside and is being issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, maintains several significant Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency (DHA) under this FSS, including Blanket Purchase Agreements (BPAs) valued up to $6.5 million. These contract vehicles allow federal healthcare providers to issue task orders for PYLARIFY and other radiopharmaceutical products to support medical imaging programs across military treatment facilities, VA medical centers, and other government healthcare providers.
Quick answers
Who was awarded contract 36C26025F0276?
36C26025F0276 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 1, 2025.
How much is contract 36C26025F0276 worth?
The government has obligated $721,744 on 36C26025F0276.
Is contract 36C26025F0276 an order under another contract?
Yes. 36C26025F0276 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0276 competed?
The extent of competition for 36C26025F0276 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award